Background: Infantile Systemic Hyalinosis (ISH) is a very rare autosomal recessive disorder characterized by connective tissue involvement as hyaline deposition in skin, gastrointestinal tract, muscles, glands and other organs.
Introduction
Infantile Systemic Hyalinosis (ISH) is an autosomal recessive disorder characterized by extensive involvement of connective tissue due to deposition of amorphous hyaline [1] .
This fatal disorder usually presents at first months of life, especially first six months with widespread involvement of joints, skin, gastrointestinal tract and other parts. Joints usually are the first involved areas with swelling, pain and limited range of motions. Patients become disabled. Bones start to become osteoporotic and prone to multiple bone fractures. Skin is another involved part which becomes thickened and covered by purplish papules especially gathered on face, neck and ears. The scattered fibrous nodules on chest wall, hypertrophic gum and prominent nodules around the anus are the other manifestations of involved skin [2] .
Because of hyaline deposition in intestinal walls these patients have protein loosing entropathy and intermittent diarrhea that lead to short stature, failure to thrive, severe malnutrition, infection and septicemia and death [3] . Six of these patients died between the age of 24 and 28 months. Two of them died because of respiratory failure and pneumonia, two others died with diarrhea and one of unknown cause.
Only one patient had positive familial history of an involved sister, both (12.5%) died before the age of 18 months with septicemia. All patients had good prenatal progress and birth weights over 2200g.
In seven (87.5%) patients, first manifestations of disease were joint stiffness and limitation of movement that progressed to fixed flexion contractures. Joint stiffness began at age 1 to 7 months with a mean age of 2.5 months and only in one case it was present from birth on. Diarrhea as one of the main complaints began in average at the age of 3 months and only in one case first manifestation of disease was noticed at 40 days of life.
Skin changes occurred after involvement of joints in almost all cases with skin thickening, hyper pigmentated plaques, purplish papules especially around ears and neck (Fig. 1) . Gingival hypertrophy was seen in all cases (Fig. 2) . Clinical presentations of ISH in our patients were shown in table 1. 
) Osteoporosis
In four (50%) patients, perianal nodules were seen (Fig. 3) . Internal otosclerosis existed in two (25%) cases. Two (25%) cases had blond hairs without similarity to their parents. All patients had normal mental and cognitive functions. One patient (12.5%) had consanguineous parents. All cases had osteopenic bones on their first radiography. Height and weight growth indices were decreased in all patients. Six of patients had terminated follow-up visits and took conservative treatments with duration of 6 to 18 months. In the meantime severe diarrhea sustained and joint contractions progressed, two others never came back for examination and only once answered our phone calls. Six of patients (75%) died and two are alive but very sick.
Discussion
ISH was first described in 1978 by Nezelof and his colleagues in a 1-month Portuguese boy with painful limitation of joints movement, gingival and skin hypertrophy [4] . Since then, until 2000, about 18 cases have been reported worldwide. In 2008, following 19 reported cases from Saudi Arabia and 3 from Iran, the number of affected patients increased [2, 5, 6] .
Pathogenesis is still unknown. Histopathology of the skin and other involved organ biopsies showed deposition of amorphous eosinophilic hyaline material in the dermis and viscera [7] .
Increased type IV collagen is major responsible for joint rigidity and hyaline deposition in GI tract. Intestinal lymphangectasia is another cause for protein losing entropathy [8] [9] [10] . On the other hand, Juvenile Hyaline Fibromatosis (JHF) according to same mutations and symptoms seems to be another form of ISH [9, 11] .
Both diseases have autosomal ressesive pattern of heredity. JHF presents with nodules and papules, particularly on scalp, ears, nose and hands, gingival hypertrophy and joint contractures. JHF eventually progresses to osteoporosis in late childhood. Patients live usually 2 to 3 decades [3] .
The responsible gene for both has been mapped on chromosome 4q21. A mutation in the gene encoding ANTRX2/capillary morphogenesis protein 2 (CMG2) is the main cause of these diseases. CMG2 is a trans membrane protein which is induced during capillary morphogenesis.
This protein CMG2 has an extracellular region that contains a von Willebrand type A domain that shows strong binding to laminin and collagen IV, both of which are markedly induced in endothelial cell morphogenesis, If a mutation affects the laminin sites, severe form of ISH occurs [9, 12] .
In the Middle East, 19 reported cases from Saudi Arabia and 8 from Iran, revealed that this region has a higher incidence rate. Perhaps marriage between families and clans are main reason [2, 6, 13] .
ISH is a very devastative disease and no effective treatment has been yet reported, studies are still incomplete and continued. Oral dpenicillamin improves joint movement and flexibility in only a few cases. Physiotherapy, nutritional support and pain reductions are only effective therapy that partially improves the quality of life in these patients. Accurate diagnosis of this disease and its genetic analysis will enable families to prevent unnecessary and disturbing procedures for their children and reduce the risk of its recurrence in their families [10, 13, 14] .
Conclusion
ISH is a very rare fatal disorder and our knowledge of this genetic disorder is very limited. Reporting 8 patients from Iran and representing their clinical manifestations and follow up results may become helpful for future studies. In our study, 75% patients died before 2 years old due to severe diarrhea, malabsorption and/ or infection.
